American Society of Regional Anesthesia 2024 Guidelines Summary
I note that the evidence provided contains 2026 American Society of Anesthesiologists (ASA) guidelines rather than 2024 American Society of Regional Anesthesia and Pain Medicine (ASRA) guidelines. However, I can provide a comprehensive summary of the most recent ASRA guidelines available in the evidence.
ASRA 2025 Anticoagulation Guidelines (Fifth Edition)
The ASRA 2025 guidelines on regional anesthesia in patients receiving antithrombotic therapy maintain an "antihemorrhagic" approach with conservative interruption times for anticoagulants prior to neural blockade. 1
Key Changes from Previous Editions
Terminology shift: Guidelines now use "low dose" and "high dose" instead of "prophylactic" and "therapeutic" to better reflect patient-specific characteristics and indications 1
Drug-specific assays: New recommendations include when to obtain drug-specific laboratory tests to guide clinical practice 1
Risk stratification remains critical: The guidelines acknowledge that hemorrhagic complications from regional anesthesia are extremely rare, but potentially catastrophic 1
Methodological Approach
Evidence remains limited for large randomized controlled trials due to the rarity of complications 1
Conservative time intervals are proposed where evidence is insufficient, prioritizing patient safety over convenience 1
Each recommendation clearly notes changes from the fourth edition 1
ASRA 2025 Infection Control Guidelines
ASRA Pain Medicine published comprehensive consensus guidelines for infection control across regional anesthesia and interventional pain procedures. 2
Core Recommendations
Risk mitigation strategies tailored to different settings (office, hospital, operating room) and procedure types 2
Preoperative patient risk assessment including identification of modifiable risk factors 2
Sterile technique requirements specific to procedure bleeding risk and anatomical location 2
Equipment maintenance protocols for reusable devices and implanted systems 2
Postoperative monitoring for early detection of infectious complications 2
Diagnosis and treatment algorithms for suspected infections related to regional anesthesia and pain procedures 2
Consensus Methodology
Modified Delphi method requiring >75% agreement for final recommendations 2
More than 80 research questions addressed across multiple working groups 2
Modified US Preventive Services Task Force criteria for evidence grading 2
ASRA Point-of-Care Ultrasound (POCUS) Guidelines (2021)
ASRA recommends structured POCUS education for all regional anesthesiologists and pain physicians to diagnose complications and guide perioperative management. 3
Clinical Applications
Airway ultrasound for difficult airway prediction and confirmation 3
Lung ultrasound for pneumothorax detection and respiratory complications 3
Gastric ultrasound for aspiration risk assessment 3
Focused cardiac ultrasound for hemodynamic assessment 3
FAST examination for trauma evaluation 3
Special Populations
Specific considerations for pediatric POCUS applications 3
Integration of handheld ultrasound devices into clinical practice 3
ASRA Interventional Pain Procedures Guidelines (2015)
ASRA stratifies interventional spine and pain procedures into low-, intermediate-, and high-risk categories for bleeding complications, with procedure-specific anticoagulation management recommendations. 4
Risk Stratification Framework
Low-risk procedures: Standard ASRA anticoagulation guidelines apply 4
Intermediate-risk procedures: Modified timing based on anatomical location and compressibility 4
High-risk procedures: Require intensive patient-specific and procedure-specific considerations beyond standard regional anesthesia guidelines 4
Key Distinctions
Pain procedures differ fundamentally from regional anesthesia in targets, goals, and bleeding risk profiles 4
Recommendations are evidence-based when available, pharmacology-driven otherwise 4
Patient safety and optimal outcomes prioritized over procedural convenience 4
Important Caveats
These guidelines require continuous updating as evidence evolves, particularly regarding newer anticoagulants and novel regional anesthesia techniques 1, 2. The recommendations serve as frameworks for clinical decision-making but must be adapted to individual patient circumstances, institutional resources, and emerging evidence 1, 2, 4.